Bone Turnover Marker Monitoring for Guiding Osteoporosis Treatment Post-TKA In Post-Menopausal Women
How to Cite
OrthoEvidence. Bone Turnover Marker Monitoring for Guiding Osteoporosis Treatment Post-TKA In Post-Menopausal Women. ACE Report. 2021;21(1):2. Available from: https://myorthoevidence.com/AceReport/Report/13439
The use of bone turnover markers for monitoring the treatment of osteoporosis in postmenopausal females undergoing total knee arthroplasty: a prospective randomized studyJ Orthop Surg Res. 2021 Mar 17;16(1): 195.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Sixty-four post-menopausal women with osteoporosis scheduled for a unilateral total knee arthroplasty (TKA) were randomized to receive anti-osteoporosis treatment (alendronate; calcitriol; calcium carbonate) guided by bone turnover marker monitoring (n=32) or a standard 3 month anti-osteoporosis treatment (n=32). Outcomes of interest included duration of treatment, incidence of adverse reactions t...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE